Genetic and molecular alterations in pancreatic cancer: implications for personalized medicine.
about
Pancreatic Cancer Epidemiology, Detection, and Management.S100P antibody-mediated therapy as a new promising strategy for the treatment of pancreatic cancer.Genomic Variations in Pancreatic Cancer and Potential Opportunities for Development of New Approaches for Diagnosis and Treatment.Pancreatic cancer: advances in treatment.Disrupting the balance between tumor epithelia and stroma is a possible therapeutic approach for pancreatic cancer.Personalized- and one- medicine: bioinformatics foundation in health and its economic feasibilityTargeting insulin-like growth factor 1 receptor inhibits pancreatic cancer growth and metastasis.Expression and clinical significance of microRNA-1246 in human oral squamous cell carcinomaExpression of miR-148/152 family as potential biomarkers in non-small-cell lung cancerClinical implications of miRNAs in the pathogenesis, diagnosis and therapy of pancreatic cancer.Aberrant expression of microRNA-26b and its prognostic potential in human cervical cancer.Mitochondria and chloroplasts shared in animal and plant tissues: significance of communication.TAp73 loss favors Smad-independent TGF-β signaling that drives EMT in pancreatic ductal adenocarcinoma.Decreased miR-503 expression in gastric cancer is inversely correlated with serum carcinoembryonic antigen and acts as a potential prognostic and diagnostic biomarker.Will detection of microRNA biomarkers in blood improve the diagnosis and survival of patients with pancreatic cancer?Precision Immuno-Oncology: Prospects of Individualized Immunotherapy for Pancreatic Cancer.The evolution into personalized therapies in pancreatic ductal adenocarcinoma: challenges and opportunities.Depletion of tumor-associated macrophages switches the epigenetic profile of pancreatic cancer infiltrating T cells and restores their anti-tumor phenotype.
P2860
Q26768506-B571D121-72F3-4D66-B222-C916515EB70EQ33685170-4C43A4D4-D649-461B-A885-2C08C160F290Q33838679-4C862977-72E8-4563-ACAE-7E0ED4D86FEFQ33948334-086BA49A-7072-443A-A01B-AE99F33AA5FDQ34413596-EF7F55E5-59A2-484E-A8BA-C34E70F16FA4Q35005961-423E520A-B8F3-4CF2-86DC-BC748F38E4EEQ35165301-9B383332-CE47-4A5E-A6FD-2C2D3F7D56BDQ35211914-4D223D62-EFFF-445F-A01E-B1C6489636D4Q35565052-6B24B138-9498-4BA4-842F-7C39D6112397Q35735278-506D719F-DE59-487F-9F9A-4E6102829909Q35854256-05558539-140F-4150-BFCA-4CC9D2BE3287Q38501275-14AF26E8-0CEC-4743-89F3-78BF909EDDECQ39947989-7D4C18BC-F7B8-4DCD-8511-7C150E26BF0BQ40570815-3A74A3A8-0B57-4942-864F-17BBBA60C784Q42830530-64A57764-188A-4650-A3E5-5D79EBCFB228Q47701712-47851C0A-9EC2-42E8-A95E-39D1DD266C8FQ48098689-56BF5EC3-632B-4ABC-8BCA-BC842F8568B9Q50545391-5F850DEF-DAB1-4296-889A-A4A79F34C376
P2860
Genetic and molecular alterations in pancreatic cancer: implications for personalized medicine.
description
2013 nî lūn-bûn
@nan
2013 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
Genetic and molecular alterati ...... ons for personalized medicine.
@ast
Genetic and molecular alterati ...... ons for personalized medicine.
@en
Genetic and molecular alterati ...... ons for personalized medicine.
@nl
type
label
Genetic and molecular alterati ...... ons for personalized medicine.
@ast
Genetic and molecular alterati ...... ons for personalized medicine.
@en
Genetic and molecular alterati ...... ons for personalized medicine.
@nl
prefLabel
Genetic and molecular alterati ...... ons for personalized medicine.
@ast
Genetic and molecular alterati ...... ons for personalized medicine.
@en
Genetic and molecular alterati ...... ons for personalized medicine.
@nl
P2093
P2860
P921
P356
P1476
Genetic and molecular alterati ...... ons for personalized medicine.
@en
P2093
Changyi Chen
Fisher E William
Jianbin Xiang
Richard A Gibbs
Yantian Fang
Zongyou Chen
P2860
P304
P356
10.12659/MSM.889636
P577
2013-10-31T00:00:00Z